Yongzheng Bao

Shaoguan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

VSIG2 Promotes Osteosarcoma Cisplatin Resistance Via Activating PI3K/AKT/mTOR Pathway.

VSIG2 Promotes Osteosarcoma Cisplatin Resistance Via Activating PI3K/AKT/mTOR Pathway.

Journal: Current molecular medicine

Published: October 24, 2025

High expression of small nucleolar RNA host gene 3 predicts poor prognosis and promotes bone metastasis in prostate cancer by activating transforming growth factor-beta signaling.

High expression of small nucleolar RNA host gene 3 predicts poor prognosis and promotes bone metastasis in prostate cancer by activating transforming growth factor-beta signaling.

Journal: Bioengineered

Published: January 15, 2022

Oncogenic gene TRIM10 confers resistance to cisplatin in osteosarcoma cells and activates the NF-κB signaling pathway.

Oncogenic gene TRIM10 confers resistance to cisplatin in osteosarcoma cells and activates the NF-κB signaling pathway.

Journal: Cell biology international

Published: June 10, 2020

Long noncoding RNA XIST knockdown relieves the injury of microglia cells after spinal cord injury by sponging miR-219-5p.

Long noncoding RNA XIST knockdown relieves the injury of microglia cells after spinal cord injury by sponging miR-219-5p.

Journal: Open medicine (Warsaw, Poland)

Published: June 02, 2020

Validation of the Palliative Prognostic Index, Performance Status-Based Palliative Prognostic Index and Chinese Prognostic Scale in a home palliative care setting for patients with advanced cancer in China.

Validation of the Palliative Prognostic Index, Performance Status-Based Palliative Prognostic Index and Chinese Prognostic Scale in a home palliative care setting for patients with advanced cancer in China.

Journal: BMC palliative care

Published: May 17, 2020

Simultaneous determination of TUG-891 and its metabolites in rat plasma using LC-HRMS with application to preclinical pharmacokinetic study.

Simultaneous determination of TUG-891 and its metabolites in rat plasma using LC-HRMS with application to preclinical pharmacokinetic study.

Journal: Biomedical chromatography : BMC

Published: February 27, 2020

Feasibility and Safety of Cervical Kinematic Magnetic Resonance Imaging in Patients with Cervical Spinal Cord Injury without Fracture and Dislocation.

Feasibility and Safety of Cervical Kinematic Magnetic Resonance Imaging in Patients with Cervical Spinal Cord Injury without Fracture and Dislocation.

Journal: Orthopaedic surgery

Published: September 13, 2019

Clinical evaluation of neoadjuvant chemotherapy for osteosarcoma.

Clinical evaluation of neoadjuvant chemotherapy for osteosarcoma.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: August 20, 2019

Overexpression of TBL1XR1 confers tumorigenic capability and promotes recurrence of osteosarcoma.

Overexpression of TBL1XR1 confers tumorigenic capability and promotes recurrence of osteosarcoma.

Journal: European journal of pharmacology

Published: June 14, 2018

Mir-664 promotes osteosarcoma cells proliferation via downregulating of FOXO4.

Mir-664 promotes osteosarcoma cells proliferation via downregulating of FOXO4.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 16, 2015

Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.

Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.

Journal: Clinical and experimental medicine

Published: May 25, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026